如何为氟-18氟代脱氧葡萄糖正电子发射断层显像心肌存活性评估准备患者
本综述以临床病例说明18F-FDG PET在心肌存活性评估中的作用,探讨不同代谢准备方案及其临床意义,指出高胰岛素正血糖钳夹仍是最有效技术,而静脉葡萄糖负荷加胰岛素等替代方案因效率和实用性日益被采用,强调标准化且可个体化调整的代谢准备方法的重要性。
要点
- 18F-FDG PET通过评估心肌代谢活性区分存活心肌与瘢痕组织。
- 高胰岛素正血糖钳夹仍是最有效的代谢准备技术。
- 静脉葡萄糖负荷加胰岛素等替代方案因效率和实用性日益被采用。
核心结论
- 心肌存活性评估可用于部分中重度缺血性心肌病患者的临床管理。
- 18F-FDG PET是评估心肌代谢活性、区分存活心肌与瘢痕组织的关键工具。
- 最佳代谢准备对提高心肌葡萄糖摄取和确保成像准确至关重要,尤其对胰岛素抵抗程度不一的糖尿病患者。
- 高胰岛素正血糖钳夹仍是最有效的技术,而静脉葡萄糖负荷加胰岛素等替代方案因效率和实用性日益被采用。
- 本综述强调标准化且可个体化调整的代谢准备方法的重要性,需考虑患者个体因素和机构资源。
研究设计与样本
- 综述,包含一例临床病例,探讨不同代谢准备方案及其临床意义。
主要发现
- 高胰岛素正血糖钳夹仍是最有效的代谢准备技术。
- 静脉葡萄糖负荷加胰岛素等替代方案因效率和实用性日益被采用。
- 对上述方法的比较分析为不同患者群体的适用性提供了见解。
- 新出现的文献支持优化的PET成像方案,有助于指导中重度缺血性心肌病患者血运重建的临床决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myocardial viability assessment can be valuable in the management of selected patients with moderate-to-severe ischemic cardiomyopathy. Among the viability imaging modalities, 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) is a key tool for evaluating myocardial metabolic activity, helping to distinguish viable myocardium from scar tissue. Optimal metabolic preparation is crucial to enhance myocardial glucose uptake and ensure accurate imaging, particularly in diabetic patients with variable insulin resistance. This review presents a clinical case illustrating the role of 18F-FDG PET in myocardial viability assessment, explores different metabolic preparation protocols, and examines their clinical implications. The hyperinsulinemic euglycemic clamp (HEC) remains the most effective technique; however,alternative protocols, such as intravenous glucose loading with insulin, are increasingly utilized for their efficiency and practicality. A comparative analysis of these methods provides insight into their suitability for different patient populations. This review also emphasizes the importance of a standardized yet adaptable approach to metabolic preparation,considering individual patient factors and institutional resources. Emerging literature supporting optimized PET imaging protocols is highlighted to help guide clinical decision-making for revascularization in patients with moderate-to-severe ischemic cardiomyopathy.
引用
- Lima BB, Kronenberg MW, Carr CM, et al. How to prepare patients for fluorine-18 fluorodeoxyglucose positron emission tomography myocardial viability assessment. J Nucl Cardiol. 2025. PMID: 40907935. doi:10.1016/j.nuclcard.2025.102480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。